Nephrocare IPO Details

he IPO comprises a Fresh Issue of equity shares aggregating up to Rs. 353.41 crores and an Offer for Sale (OFS) of up to 12,792,056 equity shares by existing shareholders.

Promoters participating in the OFS include Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte. Ltd., and Investcorp Growth Opportunity Fund.

The issue is managed by ICICI Securities, Ambit Private Limited, IIFL Capital Services, and Nomura Financial Advisory and Securities

The equity shares are proposed to be listed on both BSE and NSE, with ‘in-principle’ approvals to be received from both exchanges.

... Read more

Nephrocare IPO Strengths

  • Nephrocare (NephroPlus) is India's largest dialysis service provider in terms of the number of dialysis sessions performed and centers operated. As of FY2024, it operated 419 centers across 196 cities and 22 states/UTs .
  • It has entered into long-term Public Private Partnerships (PPPs) and hospital tie-ups that provide visibility and stability of revenue. 190 of its centers are government partnerships .
  • NephroPlus has also expanded internationally to the Philippines, Uzbekistan, and operated one center in Kenya, giving it a strategic edge over India-only players .
  • The company uses proprietary platforms like CarePro for real-time clinical and operational data, improving service consistency and efficiency .

Nephrocare IPO Weaknesses

  • 45.35% of its operational centers are under government partnerships. Any policy changes or non-renewal of PPP contracts may adversely affect operations.
  • Operations are working capital intensive. The company depends heavily on timely reimbursements from government schemes and hospitals .
  • Its international business operations expose it to currency fluctuations and regulatory risk in other jurisdictions .
  • NephroPlus primarily focuses on dialysis and related services. Over-reliance on a single specialty makes it vulnerable to market or tech disruptions in nephrology care .

Nephrocare Revenue & Profit

Revenue
Profit
Loss
All value in ₹ Billions

4.43

5.75

7.70

10

8

6

4

2

0

2023
2024
2025

Nephrocare IPO Dates

Open DateTo be announced
Close DateTo be announced
Allotment Date To be announced
Initiation of RefundsCredit of Shares to Demat Account
To be announced
Listing DateTo be announced

Nephrocare IPO Lot Size

Minimum Lot SizeTo be announced
Maximum Lot SizeTo be announced

Seize the Opportunity! Apply for Nephrocare IPO

No AMC Charges
Free Demat Account Opening
Low DP Charges
Zero AMC Charges for First Year
Free Expert Research
Low DP Charges (Rs. 10 only)
Free IPO Report & Research

Nephrocare IPO Subscription Breakup

QIBsTo be announced
Non Institutional InvestorsTo be announced
Retail InvestorsTo be announced

How to Apply for Nephrocare IPO?

Step 1

First, you need to visit the IPO section on our website.

Step 2

Then, click on the 'IPO Listing' option to view the IPO.

Step 3

Open the Nephrocare Limited IPO by tapping on it.

Step 4

You will see an option to subscribe that you need to click on.

Step 5

Now that you can see the IPO details, you must enter details like cut-off price, number of lots, and UPI ID.

Step 6

Next, verify your details and select the 'Subscribe' option to complete the bidding.

You have completed your bidding for the Nephrocare Limited IPO. Log in and go to the 'IPO Transactions' section to track your allotment status.

Nephrocare IPO FAQs

Typically, IPO subscriptions close at 5:00 PM IST on the final day, but for UPI-based retail investors, the cut-off time is generally 4:00 PM IST to ensure payment authorization is completed on time. Investors are advised to check the latest schedule and deadlines with their brokers or official sources before applying.

It is possible to check the Nephrocare Limited IPO allotment status on the portal of your broker or registrar. Information regarding the allotment status is also conveyed via email and SMS from issuing and holding authorities, such as the BSE, NSE, CDSL, and NSDL.

Yet to be Announced

Yet to be Announced

Yes, it is possible to revise or cancel an IPO application if you do it within the IPO subscription closing date.

The time of applying for any IPO is usually between Monday to Friday each week, which are the normal business days for the market. Still, it is recommended to contact your registrar for any further information.
Nephrocare IPO - Listing Date, Price, Lot Size, Analysis & Details